US-based Accuray has partnered with MIM Software to develop new adaptive therapy software for the TomoTherapy and CyberKnife product portfolios.

Both the firms earlier also collaborated for the development of the first iPad-based treatment plan review capability, PlanTouch.

Accuray president and CEO Joshua Levine said: "Accuray is committed to bringing innovative products and services to the market that deliver value to our customers and clinical benefits to their patients.

"We are excited to collaborate with MIM to enhance the ability of our precise, innovative tumor treatments to deliver even better tailored radiation therapy and improved outcomes for some patients."

The Accuray CyberKnife M6 Series and TomoTherapy H Series treatment solutions have been developed to cover the entire spectrum of radiation therapy needs.

The CyberKnife M6 Series is said to enable precise and high-dose distributions to be delivered to the patient with extreme accuracy over a minimum number of treatments, and is claimed to be the only robotic full-body radiosurgery system available.

The TomoTherapy H Series allows physicians to customize treatment plans for the entire range of radiation therapy patients and disease types.